Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNFRSF19 Antikörper (AA 29-44)

TNFRSF19 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN372452
  • Target Alle TNFRSF19 Antikörper anzeigen
    TNFRSF19 (Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19))
    Bindungsspezifität
    • 15
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 29-44
    Reaktivität
    • 38
    • 14
    • 8
    • 5
    • 5
    • 5
    • 5
    • 5
    Human, Maus
    Wirt
    • 37
    • 5
    Kaninchen
    Klonalität
    • 37
    • 5
    Polyklonal
    Konjugat
    • 18
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNFRSF19 Antikörper ist unkonjugiert
    Applikation
    • 37
    • 14
    • 13
    • 13
    • 7
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Spezifität
    This antibody recognizes TNFRSF19.
    Kreuzreaktivität (Details)
    Species reactivity (expected):Mouse.
    Species reactivity (tested):Human.
    Aufreinigung
    Protein G Chromatography.
    Immunogen
    A mixture of synthetic peptides corresponding to amino acids 29-44, 204-219, and 409-421 of Human TROY.
    Isotyp
    IgG
    Top Product
    Discover our top product TNFRSF19 Primärantikörper
  • Applikationshinweise
    Immunohistochemistry on Paraffin Sections: 5 μg/mL. Western blot: 0.5-2 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.5 mg/mL
    Buffer
    PBS containing 0.02 % Sodium Azide as preservative.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
  • Target
    TNFRSF19 (Tumor Necrosis Factor Receptor Superfamily, Member 19 (TNFRSF19))
    Andere Bezeichnung
    TNFRSF19 / TRADE (TNFRSF19 Produkte)
    Synonyme
    TNFRSF19 antikoerper, DKFZp468A0320 antikoerper, TAJ antikoerper, TAJ-alpha antikoerper, TRADE antikoerper, TROY antikoerper, AL023044 antikoerper, AW123854 antikoerper, TAJ-ALPHA antikoerper, Troy antikoerper, RGD1564996 antikoerper, TNF receptor superfamily member 19 antikoerper, tumor necrosis factor receptor superfamily, member 19 antikoerper, TNFRSF19 antikoerper, Tnfrsf19 antikoerper
    Hintergrund
    Analysis of EST clones and use of a signal sequence trap screening of the murine brain have lead to identification of a new member of the tumor necrosis factor receptor superfamily designated as TAJ and TROY, respectively. TAJ/TROY is a membrane protein of 423 amino acids with characteristic cysteine-rich motifs in the extracellular domain and a tumor necrosis factor receptor-associated factor (TRAF) 2 binding sequence in the cytoplasmic domain. Human TROY has 78 % identity at the amino acid level with mouse TROY. The extracellular domain of TROY has significant homology with that of EDAR (another newly identified receptor belonging to TNF receptor family) that specifies hair follicle fate. The cytoplasmic domain of TAJ is different than other TNF receptor family members. Although its cytoplasmic domain does not contain death domain, TAJ/TROY induced cell death is probably mediated through a caspase-independent pathway. TAJ-induced JNK activation was not blocked by dominant-negative inhibitors of TRAF2, TRAF5, or ASK1, which have been previously implicated in JNK activation via TNFR1 and CD40. However, coimmunoprecipitation assays revealed that TAJ is capable of binding a number of different TRAF family members, and it is possible that TAJ-induced JNKactivation is mediated by an as yet untested TRAF homolog, such as TRAF6. TROY mRNA is highly expressed in brain, prostate and embryo and moderately expressed in the heart, lung, liver.Synonyms: TAJ, TROY, Toxicity and JNK inducer, Tumor necrosis factor receptor superfamily member 19
    Gen-ID
    55504
    NCBI Accession
    NP_001191387
    UniProt
    Q9NS68
Sie sind hier:
Kundenservice